Suppr超能文献

小檗碱通过多种信号通路调节阿尔茨海默病的神经保护潜力。

Neuroprotective potential of berberine in modulating Alzheimer's disease via multiple signaling pathways.

机构信息

Department of Pharmaceutical Chemistry, Government College University, Faisalabad, Pakistan.

Department of Pharmacy, University of Agriculture, Faisalabad, Pakistan.

出版信息

J Food Biochem. 2021 Oct;45(10):e13936. doi: 10.1111/jfbc.13936. Epub 2021 Sep 14.

Abstract

Berberine is one of the most important quinoline alkaloids, which has shown numerous pharmacological activities. There are pieces of evidence that berberine serves as a promising substance for treating Alzheimer's disease (AD). Recently, numerous studies on animal models have shown the neuroprotective role of berberine. AD is a complex disease having multiple pathological factors. Berberine restrains the deposition of amyloid plaques and neurofibrillary tangles. Substantial studies have demonstrated that berberine may also exhibit the protective effect against the risk factors associated with AD. This review illustrates the role of berberine in neuroinflammation, oxidative stress and its activity against acetylcholinesterase enzyme. It also focuses on the bioavailability and safety of berberine in AD. However, more investigations are required to explore the bioavailability and safety assessment of berberine and its new perspectives in limiting the AD-related pathogenesis and risk factors. PRACTICAL APPLICATIONS: Current therapeutic measures only provide symptomatic relief against AD by slowing memory loss, resolving thinking problems and behavioral issues. In recent past years, many biological actions and potential therapeutic applications have been observed by berberine particularly in neurological diseases. Berberine has been investigated by various researchers for its activity against AD. This review demonstrates a variety of mechanisms by which berberine imparts its neuroprotective roles and provides the possible mechanism of action of berberine by which it prevents the formation of neurofibrillary tangles and disaggregation of amyloid beta plaques in AD. It also focuses that berberine limits the neuroinflammation and oxidative stress in AD. Pre-clinical aspects of berberine against AD are also discussed. Eventually, a prospect is formulated that berberine might be a therapeutically significant agent for treating and preventing AD.

摘要

小檗碱是最重要的喹啉生物碱之一,具有多种药理活性。有证据表明,小檗碱是治疗阿尔茨海默病(AD)的一种很有前途的物质。最近,大量动物模型研究表明小檗碱具有神经保护作用。AD 是一种复杂的疾病,有多种病理因素。小檗碱抑制淀粉样斑块和神经原纤维缠结的沉积。大量研究表明,小檗碱还可能对与 AD 相关的危险因素表现出保护作用。本综述说明了小檗碱在神经炎症、氧化应激及其对乙酰胆碱酯酶活性的作用。它还重点介绍了小檗碱在 AD 中的生物利用度和安全性。然而,需要更多的研究来探索小檗碱的生物利用度和安全性评估及其在限制 AD 相关发病机制和危险因素方面的新前景。

实际应用

目前的治疗措施只能通过减缓记忆力减退、解决思维问题和行为问题来提供 AD 的对症治疗。近年来,小檗碱在神经疾病方面表现出了许多生物作用和潜在的治疗应用。许多研究人员已经研究了小檗碱对 AD 的作用。本综述展示了小檗碱发挥其神经保护作用的多种机制,并提供了小檗碱的可能作用机制,即通过阻止神经原纤维缠结的形成和 AD 中β淀粉样斑块的解聚来预防 AD。它还强调小檗碱可以限制 AD 中的神经炎症和氧化应激。还讨论了小檗碱在 AD 中的临床前方面。最终得出的结论是,小檗碱可能是治疗和预防 AD 的一种具有治疗意义的药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验